• 11/30/2024

Novartis Positive on Growth for 2024

Wall Street Journal

Novartis reported an almost 5% rise in core operating profit in the fourth quarter, with sales boosted by its heart and psoriasis drugs, and said it expected high single digit earnings growth in 2024.

https://www.wsj.com/articles/novartis-net-profit-boosted-by-gain-from-sandoz-spinoff-04d1025f